Reach Us +441467840001
Human Stromal Progenitor Cells For Immunomodulation And Tissue Repair | 9623
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Human stromal progenitor cells for immunomodulation and tissue repair

2nd International Conference on Tissue Science & Regenerative Medicine

Graca Alameida-Porarda

Symposium: J Tissue Sci Eng

DOI: 10.4172/2157-7552.S1.010

B one marrow derived marrow stromal cells (mscs) possess a set of several fairly unique properties which make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles for gene and drug delivery. These cells are easy to isolate, can be extensively expanded in culture without a loss of differentiativecapacity, they migrate to areas of injury, and have immunomodulatory properties. However, mscs are not invisible to the recipient's immune system, and upon in vivo administration, allogeneic mscs are able to trigger immune responses, resulting in rejection of the transplanted cells, precluding their full therapeutic potential. Here we will describe the development of immunological evasion strategies to reduce mscs immunogenicity allowing higher levels of engraftment in an allogeneic transplantation setting
Gra?a Almeida-Porada, M.D., Ph.D., is a Professor of Regenerative Medicine at the Institute for Regenerative Medicine, Wake Forest School of Medicine. Her research investigates the biological properties and regenerative capabilities of adult stem cells, with the goal of understanding disease processes and developing novel approaches to cell therapy and tissue repair. She is a reviewer and serves on the Editorial Board of multiple scientific journals. She has authored more than 100 scientific publications, reviews and book chapters